Sign in

CIK 0001438533

  • Large accelerated filer

Travere Therapeutics, Inc.

Sign in to watch
Ticker
TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
262383102
Phone
+1 888-969-7879
Business address
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
Former names
Retrophin, Inc., Desert Gateway, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$79,495,607
in 10 filings, $79.5M under 10b5-1 plans

Net −$79,495,607. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-05-08 Squarer Ron Director Grant or award · Employee stock option (right to buy) +8,000 8,000
2019-05-08 Orwin John A Director Grant or award +2,000 8,875
2019-05-08 Orwin John A Director Grant or award · Employee stock option (right to buy) +8,000 8,000
2019-05-08 Meckler Jeffrey A Director Grant or award +2,000 61,000
2019-05-08 Meckler Jeffrey A Director Grant or award · Employee stock option (right to buy) +8,000 8,000
2019-05-08 LYONS GARY A Director Grant or award +2,000 31,000
2019-05-08 LYONS GARY A Director Grant or award · Employee stock option (right to buy) +8,000 8,000
2019-05-08 KOZARICH JOHN W Director Grant or award +2,000 29,000
2019-05-08 KOZARICH JOHN W Director Grant or award · Employee stock option (right to buy) +8,000 8,000
2019-05-08 Coughlin Timothy P Director Grant or award +2,000 29,000
2019-05-08 Coughlin Timothy P Director Grant or award · Employee stock option (right to buy) +8,000 8,000
2019-05-08 Baynes Roy D. Director Grant or award +2,000 11,000
2019-05-08 Baynes Roy D. Director Grant or award · Employee stock option (right to buy) +8,000 8,000
2019-05-08 ASELAGE STEVE Director Grant or award +2,000 259,642
2019-05-08 ASELAGE STEVE Director Grant or award · Employee stock option (right to buy) +8,000 8,000
2019-02-19 ROTE WILLIAM E. Senior Vice President, R&D Sale −1,250 $21.52 $27K 13,810
2019-02-15 ROTE WILLIAM E. Senior Vice President, R&D Sale −1,250 $21.44 $27K 15,060
2019-02-12 REED ELIZABETH E SVP, GC & Corporate Secretary Sale −884 $21.50 $19K 14,558
2019-02-12 ROTE WILLIAM E. Senior Vice President, R&D Sale −992 $21.50 $21K 16,007
2019-02-12 Clague Laura Chief Financial Officer Sale −1,016 $21.50 $22K 10,000

Page 47 of 51 · 1,020 trades